Latest News

12345678910
Prediction: These Will Be AMD’s and Nvidia’s Stock Prices by 2028fool.com
Shares of both semiconductor companies can soar impressively, but one of them seems primed for bigger gains.
Via The Motley Fool · November 22, 2026
I'm Raising My Fair Value Estimate for Berkshire Hathaway Stock. Here's What I Think It's Worth.fool.com
My new number is around 22% over today's stock price. And one part of the business carries most of it.
Via The Motley Fool · November 22, 2026
Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?marketbeat.com
Via MarketBeat · November 22, 2026
If Your Social Security Benefit Is Above This Average, You're Ahead of Most Retireesfool.com
Beating the national Social Security average is one thing, but whether that check actually covers retirement is a far tougher test.
Via The Motley Fool · November 22, 2026
Gilead Sciences Has Raised Its Dividend for 11 Straight Years. Here’s Why the Streak Looks Safe.fool.com
Gilead's consistent cash flows from HIV therapies help sustain its dividend.
Via The Motley Fool · November 22, 2026
Neurocrine Biosciences Sees INGREZZA Growth, Awaits Key 2027 Trial Resultsmarketbeat.com
Neurocrine Biosciences (NASDAQ:NBIX) expects continued growth from its largest medicine, INGREZZA, despite pricing pressure, while preparing for multiple clinical trial readouts in 2027, executives said at a Jefferies-hosted discussion. Chief Executive Officer Kyle Gano said the company’s third-qua
Via MarketBeat · November 22, 2026
Is Nvidia a Buy at $125? Here's My Honest Takefool.com
The top AI stock is down nearly 50%. Is it a buy?
Via The Motley Fool · November 22, 2026
Bloom Energy Stock Has Crashed Nearly 60%. Is It a Once-in-a-Decade Opportunity at $145, or Should You Keep Waiting for a Bigger Drop?fool.com
Bloom Energy has plunged about 60% from its peak, even as revenue and profits surge. Is it a screaming buy or still expensive?
Via The Motley Fool · November 22, 2026
Keysight Technologies: The Tollbooth on the Technology Superhighwaymarketbeat.com
Via MarketBeat · November 22, 2026
It's Official! Social Security's Trump Bump-Driven 2027 COLA Will Provide a Unique "Bonus" for Up to 35 Million Retirees.fool.com
This’ll be the first silver lining for tens of millions of retirees since 2023.
Via The Motley Fool · November 22, 2026
Why Broadcom Stock Could Double by 2030fool.com
Broadcom stock is slightly lower this year, even as its AI chip revenue just tripled.
Via The Motley Fool · November 22, 2026
Compass Pathways Sees Potential Fast FDA Review for Psilocybin Depression Treatmentmarketbeat.com
Compass Pathways (NASDAQ:CMPS) has completed its application to the U.S. Food and Drug Administration for COMP360, its investigational synthetic psilocybin treatment for treatment-resistant depression, and expects to be ready to launch by the end of the year, subject to approval. Speaking at a Jeff
Via MarketBeat · November 22, 2026
Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy?fool.com
J&J is a healthcare giant performing very well right now, but it won't be a great fit for every investor.
Via The Motley Fool · November 22, 2026
Why We’re Waiting to Buy the AI Dipinvestorplace.com
Luke Lango explains three pressures on AI stocks, why he’s waiting to buy the dip, and where opportunities beyond Nvidia could emerge.
Via InvestorPlace · November 22, 2026
Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.marketbeat.com
Via MarketBeat · November 22, 2026
Prediction: Anthropic Will Be the World’s Most Valuable Company by 2030fool.com
Anthropic is already one of the largest companies in the world, and its growth could carry it past all of them.
Via The Motley Fool · November 22, 2026
SOXX and DRAM Are Down Between 35.6% and 51.9% From Their Highs. Here’s an Even Better Growth Stock ETF to Buy During the Nasdaq Correction.fool.com
The Vanguard Mega Cap Growth ETF invests in both the infrastructure and application layers of artificial intelligence (AI).
Via The Motley Fool · November 22, 2026
J.P. Morgan Says Tesla’s Robotaxi Fleet Could Match Waymo’s Miles by Late 2027 With 18,000 Cars. The Number That Matters Is How Much Each Car Earns.fool.com
The robotaxi battle will be won and lost over the total cost of ownership per mile.
Via The Motley Fool · November 22, 2026
PepsiCo vs. Starbucks: Which Consumer Goods Stock Is a Better Buy for 2027?fool.com
Starbucks trades at nearly twice PepsiCo's forward earnings multiple, but its free cash flow and loyalty-driven model raise a sharper question about which premium is justified.
Via The Motley Fool · November 22, 2026
What’s Going on with The Trade Desk Stock? 3 Reasons Investors Are Losing Confidence.fool.com
Is The Trade Desk a turnaround story or a value trap?
Via The Motley Fool · November 22, 2026
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?fool.com
Johnson & Johnson's drug-and-device product mix faces off against Pfizer's high-stakes oncology and obesity bets, with a valuation gap that may sway your choice.
Via The Motley Fool · November 22, 2026
If I Were Building a Portfolio From Scratch With $10,000, I’d Anchor It With This Unassuming Value Stockfool.com
This stock has beaten the S&P 500 over the past 25 years and outperforms during downturns.
Via The Motley Fool · November 22, 2026
Abeona Therapeutics Sees ZEVASKYN Treatments Picking Up in 2027 as Centers Ramp Upmarketbeat.com
Abeona Therapeutics (NASDAQ:ABEO) expects treatment activity for its gene therapy ZEVASKYN to increase in 2027 as more qualified treatment centers begin treating patients, executives said during a fireside chat with Jefferies biotech analyst Maury Raycroft. Chief Executive Vish Seshadri said the co
Via MarketBeat · November 22, 2026
Monday.com vs. Okta: Which Tech Stock Is a Better Buy for 2027?fool.com
Monday.com trades at a far lower forward P/E than Okta, but its growth and cash flow quality raise a question about which software leader deserves a spot in your portfolio.
Via The Motley Fool · November 22, 2026
Disney Just Hit a 52-Week High. 3 Reasons It Still Has Room to Run.fool.com
Record parks and experiences demand contradicts fears of a consumer spending slowdown.
Via The Motley Fool · November 22, 2026
Bargain Hunting: Why Off-Price Retail Is Winningmarketbeat.com
Via MarketBeat · November 22, 2026
History Shows: Wayne Gretzky and Warren Buffett Can Teach Us About Investingfool.com
Wayne Gretzky and Warren Buffett might be an unlikely team, but they shared a winning attitude that can help you make money in the stock market.
Via The Motley Fool · November 22, 2026
Is Netflix a Buy in November? The Bull and Bear Cases.fool.com
Netflix shares have fallen nearly 47% from their 52-week high. Is this a rare opportunity to buy a highly profitable entertainment business at a reasonable valuation?
Via The Motley Fool · November 22, 2026
Altria Yields 5.8% and Has Raised Its Dividend 61 Times in 57 Years. Here's Exactly How Much $5,000 Invested Pays Each Year.fool.com
Investors starting out with relatively small stakes can extract a fair amount of income from Altria.
Via The Motley Fool · November 22, 2026
Not Lucid. Not Ford. The EV Stock Most Likely to Catch Every Refunded Cybertruck Buyer.fool.com
With Tesla ending production of the Cybertruck, EV buyers have one clear destination.
Via The Motley Fool · November 22, 2026
Home Depot Just Delivered Great News to Investorsfool.com
Home Depot reported its best same-store sales growth in years.
Via The Motley Fool · November 22, 2026
Here’s How Many Shares of Coca-Cola You’d Need for $10,000 in Yearly Dividends.fool.com
It would be a tough ask if you're starting from scratch, but doable over time.
Via The Motley Fool · November 22, 2026
Hikma Pharmaceuticals Confident on 2026 Targets Despite Flat Injectables Salesmarketbeat.com
Hikma Pharmaceuticals (LON:HIK) expects to meet its 2026 commitments, with strong performance in its Middle East and North Africa branded medicines business and prescription drugs helping offset a flat year for injectables, CEO Said Darwazah said. Speaking at a Jefferies event, Darwazah said Hikma
Via MarketBeat · November 22, 2026
The Stock Market Is Doing Something for Only the 5th Time This Century, and History Says It's Obvious What Comes Next for Stocksfool.com
If things seem too perfect for investors, they often are.
Via The Motley Fool · November 22, 2026
Slide's 5-Year Outlook: Proprietary Tech Moat Solidifies Lead in Coastal Insurance Marketsfool.com
This under-the-radar property insurance stock boasts a Superscore of 90 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · November 22, 2026
3 Retirement Expenses You May Not Be Prepared For -- But Need to Befool.com
Don't let these costs catch you off guard.
Via The Motley Fool · November 22, 2026
3 Reasons to Claim Social Security at 70fool.com
It's one of the best ways to maximize lifetime benefits.
Via The Motley Fool · November 22, 2026
Here's the Average Social Security Benefit at 62 vs. 70fool.com
Waiting until 70 could mean a much larger monthly check, but the early-claiming head start many retirees overlook may tilt the math more than expected.
Via The Motley Fool · November 22, 2026
Billionaire Tech Investor Philippe Laffont Just Loaded Up on These 4 AI Stocksfool.com
Laffont was busy buying shares of agentic AI stocks in Q3.
Via The Motley Fool · November 22, 2026
Guardant Health Sees Shield Coverage Boost in 2027, Holds Cash Flow Break-Even Targetmarketbeat.com
Guardant Health (NASDAQ:GH) expects expanded insurance coverage for its Shield screening test and continued growth in its cancer testing portfolio to support its business in 2027, while maintaining a target of reaching free cash flow break-even in the fourth quarter of that year. Speaking at a comp
Via MarketBeat · November 22, 2026
41.6% of Berkshire Hathaway's $358 Billion Portfolio Is Parked in 3 Artificial Intelligence (AI) Stocksfool.com
Berkshire's new CEO has aggressively bought one particular artificial intelligence stock this year.
Via The Motley Fool · November 22, 2026
Nike Is Down 79% From Its Peak. Here's How Much $10,000 Invested Pays in Dividends Now.fool.com
The sneaker giant's stock is down, but its yield is up.
Via The Motley Fool · November 22, 2026
XRP Is Back Under $1. Is It Finally a Buy?fool.com
Ripple's success is only loosely tied to the token.
Via The Motley Fool · November 22, 2026
Solana Just Launched New Privacy Features. Is It Worth Buying With $500 Right Now?fool.com
Solana's new privacy capabilities could position its ecosystem for substantial growth.
Via The Motley Fool · November 22, 2026
This Pipeline Partnership Raised Its Payout by 12.5% for the Third Straight Year. Here’s How Much Longer It Can Keep That Up.fool.com
MPLX can still afford to fund its massive distributions.
Via The Motley Fool · November 22, 2026
Elon Musk's Tesla and SpaceX Each Formed a Special Committee to Explore a Merger as His AI Spending Accelerates. Here's Why Combining Them Could Reshape How Investors Value Tesla's Robotaxi Business.fool.com
A Tesla-SpaceX merger could give the automaker's robotaxi business a boost.
Via The Motley Fool · November 22, 2026
F5 Sees AI and Software Renewals Driving Growth After $100 Million in AI Bookingsmarketbeat.com
F5 (NASDAQ:FFIV) sees artificial intelligence demand, software renewals and data center investments supporting its fiscal 2027 growth outlook, with some of those areas offering potential upside, executives said at a company news event. Chief Financial Officer Cooper Werner said the company entered
Via MarketBeat · November 22, 2026
What Every 60-Year-Old Should Know About Social Securityfool.com
Turning 60? Now’s the time to start thinking about Social Security.
Via The Motley Fool · November 22, 2026
Black Friday Deals for Traderstalkmarkets.com
TradingView and Trade Ideas are running Black Friday sales for traders in 2026, with up to 80% off TradingView and up to $640.80 off Trade Ideas.TradingVie
Via Talk Markets · November 22, 2026
Where Will Micron Stock Be in 3 Years?fool.com
Micron's stock has plunged in recent months, but the next three years could still be lucrative.
Via The Motley Fool · November 22, 2026